The research arm of Great Neck, N.Y.-based North Shore-Long Island Jewish Health System, called the Feinstein Institute for Medical Research, and Battelle, a research and development firm, have created a device to help control bleeding.
Together, the Feinstein Institute and Battelle created a "neural tourniquet," a technology that aims to help staunch blood loss through electronic nerve stimulation. The neural tourniquet has anticipated applications in planned surgeries and emergency medicine, as well as on the battlefield.
Additional scenarios in which the neural tourniquet may be applied include the following:
- Surgical teams may someday use the device to reduce blood loss in the operating room during planned surgeries or emergency surgeries.
- First responders could apply the device to trauma victims at accident scenes to slow blood loss.
- Soldiers, prior to missions where they could experience trauma, could use a device to proactively curb blood loss in the event they are wounded.
The neural tourniquet is slated to enter the market in the next three to five years.